← Open Payments lookup

CAROLINE BROWN: Open Payments

NPI 1235660572 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$879 in 44 payments from 15 companies in 2025. Trend: 2023 $457 · 2024 $701 · 2025 $879

Food & beverage: $879
CompanyPaymentsAmount
ABBVIE INC.9$194
Edwards Lifesciences Corporation8$157
AstraZeneca Pharmaceuticals LP7$138
PFIZER INC.2$52
Novo Nordisk Inc2$49
Lilly USA, LLC2$47
Kowa Pharmaceuticals America, Inc.3$46
Amgen Inc.2$38
Bayer Healthcare Pharmaceuticals Inc.2$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34

Products named: VRAYLAR, JARDIANCE, UBRELVY, FARXIGA, ZORYVE, QULIPTA, Kerendia, XIFAXAN.

Industry payments across TX — which companies pay providers there.